SMITH IAN F
Insider CIK 1197032 · ACOR Director · INFI Director · OPHT Director · STOK Interim CEO, Director · SLDB Director · FHTX Director · ODTX Director · VRTX EVP, COO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SLDB Solid Biosciences Inc. | M Exercise deriv | 2026-10-02 | 2026-10-06 | 3,440 | — | $0 | 3,440 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise | 2026-10-02 | 2026-10-06 | 3,440 | — | — | 141,585 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise deriv | 2026-07-02 | 2026-07-07 | 3,440 | — | $0 | 6,880 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise | 2026-07-02 | 2026-07-07 | 3,440 | — | $0 | 138,145 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | A Award deriv | 2026-06-24 | 2026-06-25 | 28,000 | $4.08 | $114.2K | 28,000 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2026-06-10 | 2026-06-11 | 77,500 | — | $0 | 77,500 | SEC↗ |
| ODTX Odyssey Therapeutics, Inc. | A Award deriv | 2026-05-07 | 2026-05-11 | 27,393 | — | $0 | 27,393 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise deriv | 2026-04-02 | 2026-04-02 | 3,441 | — | $0 | 10,320 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise | 2026-04-02 | 2026-04-02 | 3,441 | — | $0 | 134,705 | SEC↗ |
| STOK Stoke Therapeutics, Inc. | A Award deriv | 2026-02-17 | 2026-02-19 | 129,000 | — | $0 | 129,000 | SEC↗ |
| STOK Stoke Therapeutics, Inc. | A Award deriv | 2026-02-17 | 2026-02-19 | 193,000 | — | $0 | 193,000 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise deriv | 2026-01-06 | 2026-01-07 | 4,573 | — | $0 | 0 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise | 2026-01-06 | 2026-01-07 | 4,573 | — | $0 | 131,264 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2026-01-02 | 2026-01-07 | 18,012 | — | $0 | 18,012 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2026-01-02 | 2026-01-07 | 13,761 | — | $0 | 13,761 | SEC↗ |
| STOK Stoke Therapeutics, Inc. | A Award deriv | 2025-10-08 | 2025-10-14 | 570,000 | — | $0 | 570,000 | SEC↗ |
| STOK Stoke Therapeutics, Inc. | A Award deriv | 2025-10-08 | 2025-10-14 | 380,000 | — | $0 | 380,000 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise deriv | 2025-10-06 | 2025-10-07 | 4,573 | — | $0 | 4,573 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise | 2025-10-06 | 2025-10-07 | 4,573 | — | $0 | 126,692 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise deriv | 2025-07-06 | 2025-07-08 | 4,573 | — | $0 | 9,146 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise | 2025-07-06 | 2025-07-08 | 4,573 | — | $0 | 122,119 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | A Award deriv | 2025-06-17 | 2025-06-17 | 25,000 | $4.79 | $119.8K | 25,000 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2025-06-12 | 2025-06-13 | 77,500 | — | $0 | 77,500 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise deriv | 2025-04-06 | 2025-04-08 | 4,574 | — | $0 | 13,719 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise | 2025-04-06 | 2025-04-08 | 4,574 | — | $0 | 117,546 | SEC↗ |
| STOK Stoke Therapeutics, Inc. | A Award deriv | 2025-03-20 | 2025-03-20 | 238,420 | — | $0 | 238,420 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2025-01-06 | 2025-01-07 | 22,148 | — | $0 | 22,148 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2025-01-06 | 2025-01-07 | 18,293 | — | $0 | 18,293 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise deriv | 2025-01-03 | 2025-01-07 | 3,255 | — | $0 | 0 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise | 2025-01-03 | 2025-01-07 | 3,255 | — | $0 | 112,972 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise deriv | 2024-10-03 | 2024-10-04 | 3,255 | — | $0 | 3,255 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise | 2024-10-03 | 2024-10-04 | 3,255 | — | $0 | 109,717 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise deriv | 2024-07-03 | 2024-07-05 | 3,255 | — | $0 | 6,510 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise | 2024-07-03 | 2024-07-05 | 3,255 | — | $0 | 106,462 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | A Award deriv | 2024-06-26 | 2024-06-28 | 16,000 | $5.52 | $88.3K | 16,000 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2024-06-11 | 2024-06-13 | 34,400 | — | $0 | 34,400 | SEC↗ |
| STOK Stoke Therapeutics, Inc. | A Award deriv | 2024-06-05 | 2024-06-07 | 7,639 | — | $0 | 7,639 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise deriv | 2024-04-03 | 2024-04-05 | 3,256 | — | $0 | 9,765 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise | 2024-04-03 | 2024-04-05 | 3,256 | — | $0 | 103,207 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2024-01-03 | 2024-01-05 | 13,021 | — | $0 | 13,021 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2024-01-03 | 2024-01-05 | 15,112 | — | $0 | 15,112 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise deriv | 2024-01-03 | 2024-01-05 | 15,570 | — | $0 | 0 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise | 2024-01-03 | 2024-01-05 | 15,570 | — | $0 | 99,948 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | A Award deriv | 2023-12-08 | 2023-12-12 | 26,977 | — | $0 | 26,977 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise deriv | 2023-10-03 | 2023-10-05 | 15,569 | — | $0 | 15,570 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise | 2023-10-03 | 2023-10-05 | 15,569 | — | $0 | 84,378 | SEC↗ |
| STOK Stoke Therapeutics, Inc. | A Award deriv | 2023-09-19 | 2023-09-20 | 96,340 | — | $0 | 96,340 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise deriv | 2023-07-03 | 2023-07-06 | 15,570 | — | $0 | 31,139 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise | 2023-07-03 | 2023-07-06 | 15,570 | — | $0 | 68,809 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | A Award deriv | 2023-06-21 | 2023-06-22 | 16,000 | — | $0 | 16,000 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2023-06-06 | 2023-06-08 | 9,650 | — | $0 | 9,650 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise deriv | 2023-04-03 | 2023-06-08 | 15,569 | — | $0 | 46,709 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise | 2023-04-03 | 2023-06-08 | 15,569 | — | $0 | 53,239 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2023-01-03 | 2023-01-05 | 62,278 | — | $0 | 62,278 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise deriv | 2023-01-03 | 2023-01-05 | 1,620 | — | $0 | 0 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise deriv | 2023-01-03 | 2023-01-05 | 70,796 | — | $0 | 70,796 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise | 2023-01-03 | 2023-01-05 | 1,620 | — | $0 | 37,670 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2022-12-13 | 2022-12-15 | 9,650 | — | $0 | 9,650 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award | 2022-12-02 | 2022-12-05 | 13,172 | — | $0 | 356,380 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise deriv | 2022-10-03 | 2022-10-04 | 24,312 | — | $0 | 24,312 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise | 2022-10-03 | 2022-10-04 | 24,312 | — | $0 | 343,208 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise deriv | 2022-07-03 | 2022-07-06 | 24,313 | — | $0 | 48,624 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise | 2022-07-03 | 2022-07-06 | 24,313 | — | $0 | 318,896 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | A Award deriv | 2022-06-21 | 2022-06-22 | 16,000 | — | $0 | 16,000 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2022-06-07 | 2022-06-09 | 51,000 | — | $0 | 51,000 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise deriv | 2022-04-03 | 2022-04-05 | 24,313 | — | $0 | 72,937 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise | 2022-04-03 | 2022-04-05 | 24,313 | — | $0 | 294,583 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2022-01-03 | 2022-01-05 | 194,500 | — | $0 | 194,500 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2022-01-03 | 2022-01-05 | 97,250 | — | $0 | 97,250 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | A Award deriv | 2021-06-23 | 2021-06-24 | 12,530 | — | $0 | 12,530 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2021-06-16 | 2021-06-21 | 30,000 | — | $0 | 30,000 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | A Award deriv | 2021-04-27 | 2021-04-29 | 25,060 | $11.50 | $288.2K | 25,060 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2021-01-04 | 2021-01-06 | 389,000 | — | $0 | 389,000 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award | 2020-12-10 | 2020-12-14 | 270,270 | $3.70 | $1000.0K | 270,270 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2020-06-16 | 2020-06-18 | 200,000 | — | $0 | 200,000 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2020-04-15 | 2020-04-16 | 40,000 | — | $0 | 40,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2018-06-29 | 2018-07-03 | 23,375 | — | $0 | 10,625 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2018-06-29 | 2018-07-03 | 23,375 | $131.89 | $3.08M | 70,074 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2018-06-29 | 2018-07-03 | 4,741 | $165.22 | $783.3K | 65,333 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2018-06-29 | 2018-07-03 | 18,634 | $166.57 | $3.10M | 46,699 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | A Award deriv | 2018-06-27 | 2018-06-29 | 15,000 | — | $0 | 15,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2018-06-22 | 2018-06-26 | 4,250 | — | $0 | 12,750 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2018-06-22 | 2018-06-26 | 4,250 | $109.14 | $463.8K | 50,949 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2018-06-22 | 2018-06-26 | 4,250 | $160.00 | $680.0K | 46,699 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | M Exercise deriv | 2018-06-15 | 2018-06-19 | 15,000 | — | $0 | 0 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | M Exercise deriv | 2018-06-15 | 2018-06-19 | 10,000 | — | $0 | 0 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | M Exercise | 2018-06-15 | 2018-06-19 | 15,000 | $13.80 | $207.0K | 25,000 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | M Exercise | 2018-06-15 | 2018-06-19 | 10,000 | $25.45 | $254.5K | 10,000 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | S Sale | 2018-06-15 | 2018-06-19 | 25,000 | $31.42 | $785.5K | 0 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2018-06-12 | 2018-06-14 | 20,000 | — | $0 | 20,000 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2018-06-12 | 2018-06-14 | 4,000 | — | $0 | 4,000 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award | 2018-06-12 | 2018-06-14 | 22,857 | $1.75 | $40.0K | 45,845 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2018-05-15 | 2018-05-16 | 217 | $155.78 | $33.8K | 46,699 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2018-05-11 | 2018-05-15 | 2,155 | — | $0 | 15,086 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2018-05-11 | 2018-05-15 | 1,941 | — | $0 | 21,358 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2018-05-11 | 2018-05-15 | 1,941 | $86.52 | $167.9K | 50,795 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2018-05-11 | 2018-05-15 | 2,155 | $91.05 | $196.2K | 48,854 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2018-05-11 | 2018-05-15 | 4,096 | $155.00 | $634.9K | 46,699 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | M Exercise deriv | 2018-05-02 | 2018-05-04 | 10,000 | — | $0 | 0 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | S Sale | 2018-05-02 | 2018-05-04 | 6,323 | $23.86 | $150.9K | 0 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | M Exercise | 2018-05-02 | 2018-05-04 | 10,000 | $20.16 | $201.6K | 10,000 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | S Sale | 2018-05-02 | 2018-05-04 | 3,677 | $23.46 | $86.3K | 6,323 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2018-04-26 | 2018-04-27 | 2,125 | — | $0 | 2,125 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2018-04-26 | 2018-04-27 | 51,000 | — | $0 | 17,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2018-04-26 | 2018-04-27 | 2,125 | $96.87 | $205.8K | 48,824 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2018-04-26 | 2018-04-27 | 51,000 | $109.14 | $5.57M | 99,824 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2018-04-26 | 2018-04-27 | 53,125 | $160.12 | $8.51M | 46,699 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2018-04-25 | 2018-04-27 | 4,250 | — | $0 | 0 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2018-04-25 | 2018-04-27 | 2,156 | — | $0 | 17,241 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2018-04-25 | 2018-04-27 | 7,766 | — | $0 | 23,299 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2018-04-25 | 2018-04-27 | 9,790 | $155.62 | $1.52M | 49,399 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2018-04-25 | 2018-04-27 | 19,478 | $154.98 | $3.02M | 59,189 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2018-04-25 | 2018-04-27 | 7,766 | $86.52 | $671.9K | 78,667 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2018-04-25 | 2018-04-27 | 2,156 | $91.05 | $196.3K | 70,901 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2018-04-25 | 2018-04-27 | 4,250 | $77.31 | $328.6K | 68,745 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2018-04-25 | 2018-04-27 | 2,700 | $156.78 | $423.3K | 46,699 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2018-02-06 | 2018-02-08 | 19,566 | — | $0 | 19,566 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2018-02-06 | 2018-02-08 | 15,170 | — | $0 | 56,058 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2018-02-06 | 2018-02-08 | 8,437 | — | $0 | 64,495 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2018-01-16 | 2018-01-17 | 2,125 | — | $0 | 4,250 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2018-01-16 | 2018-01-17 | 400 | $157.02 | $62.8K | 41,788 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2018-01-16 | 2018-01-17 | 2,125 | $96.87 | $205.8K | 43,013 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2018-01-16 | 2018-01-17 | 500 | $159.29 | $79.6K | 40,888 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2018-01-16 | 2018-01-17 | 400 | $158.11 | $63.2K | 41,388 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2018-01-16 | 2018-01-17 | 825 | $155.80 | $128.5K | 42,188 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-11-15 | 2017-11-17 | 7 | $147.29 | $1.0K | 40,888 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2017-11-06 | 2017-11-07 | 4,250 | — | $0 | 4,250 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2017-11-06 | 2017-11-07 | 4,250 | $77.31 | $328.6K | 45,138 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-11-06 | 2017-11-07 | 4,250 | $150.00 | $637.5K | 40,888 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2017-11-03 | 2017-11-07 | 2,155 | — | $0 | 19,397 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-11-03 | 2017-11-07 | 2,155 | $150.00 | $323.3K | 40,888 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2017-11-03 | 2017-11-07 | 2,155 | $91.05 | $196.2K | 43,043 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-10-31 | 2017-10-31 | 22,464 | $145.26 | $3.26M | 53,579 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-10-31 | 2017-10-31 | 3,791 | $148.26 | $562.1K | 41,088 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-10-31 | 2017-10-31 | 3,500 | $147.40 | $515.9K | 44,879 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-10-31 | 2017-10-31 | 5,200 | $146.39 | $761.2K | 48,379 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-10-31 | 2017-10-31 | 200 | $149.34 | $29.9K | 40,888 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-10-31 | 2017-10-31 | 32,945 | $144.47 | $4.76M | 76,043 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-10-31 | 2017-10-31 | 5,200 | $143.47 | $746.0K | 108,988 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-10-31 | 2017-10-31 | 1,700 | $142.40 | $242.1K | 114,188 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2017-10-16 | 2017-10-18 | 2,125 | — | $0 | 6,375 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-10-16 | 2017-10-18 | 850 | $156.24 | $132.8K | 116,088 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2017-10-16 | 2017-10-18 | 2,125 | $96.87 | $205.8K | 118,013 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-10-16 | 2017-10-18 | 200 | $157.07 | $31.4K | 115,888 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-10-16 | 2017-10-18 | 200 | $154.01 | $30.8K | 117,813 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-10-16 | 2017-10-18 | 875 | $155.03 | $135.7K | 116,938 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2017-08-07 | 2017-08-09 | 4,250 | — | $0 | 8,500 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2017-08-07 | 2017-08-09 | 4,250 | $77.31 | $328.6K | 120,138 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-08-07 | 2017-08-09 | 400 | $154.09 | $61.6K | 119,738 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-08-07 | 2017-08-09 | 2,600 | $155.29 | $403.8K | 117,138 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-08-07 | 2017-08-09 | 1,250 | $156.02 | $195.0K | 115,888 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2017-08-02 | 2017-08-04 | 2,155 | — | $0 | 21,552 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-08-02 | 2017-08-04 | 500 | $152.49 | $76.2K | 117,543 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-08-02 | 2017-08-04 | 500 | $153.57 | $76.8K | 117,043 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-08-02 | 2017-08-04 | 700 | $154.55 | $108.2K | 116,343 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-08-02 | 2017-08-04 | 455 | $156.09 | $71.0K | 115,888 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2017-08-02 | 2017-08-04 | 2,155 | $91.05 | $196.2K | 118,043 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2017-07-31 | 2017-08-02 | 2,125 | — | $0 | 0 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-07-31 | 2017-08-02 | 1,100 | $153.30 | $168.6K | 115,988 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2017-07-31 | 2017-08-02 | 2,125 | $83.36 | $177.1K | 118,013 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-07-31 | 2017-08-02 | 100 | $154.13 | $15.4K | 115,888 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-07-31 | 2017-08-02 | 925 | $152.24 | $140.8K | 117,088 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-07-21 | 2017-07-21 | 815 | $159.61 | $130.1K | 123,194 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-07-21 | 2017-07-21 | 200 | $162.40 | $32.5K | 115,888 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-07-21 | 2017-07-21 | 5,106 | $161.71 | $825.7K | 116,088 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-07-21 | 2017-07-21 | 2,000 | $161.01 | $322.0K | 121,194 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-07-21 | 2017-07-21 | 1,829 | $158.62 | $290.1K | 124,009 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-07-21 | 2017-07-21 | 400 | $157.56 | $63.0K | 125,838 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2017-07-19 | 2017-07-21 | 31,875 | — | $0 | 2,125 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2017-07-19 | 2017-07-21 | 10,775 | — | $0 | 23,707 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2017-07-19 | 2017-07-21 | 25,500 | — | $0 | 8,500 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2017-07-19 | 2017-07-21 | 55,250 | — | $0 | 12,750 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2017-07-19 | 2017-07-21 | 10,775 | $91.05 | $981.1K | 162,513 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2017-07-19 | 2017-07-21 | 25,500 | $96.87 | $2.47M | 151,738 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-07-19 | 2017-07-21 | 123,400 | $161.00 | $19.87M | 126,238 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2017-07-19 | 2017-07-21 | 31,875 | $83.36 | $2.66M | 249,638 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2017-07-19 | 2017-07-21 | 55,250 | $77.31 | $4.27M | 217,763 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2017-06-01 | 2017-06-05 | 37,383 | — | $0 | 0 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2017-06-01 | 2017-06-05 | 18,124 | — | $0 | 0 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2017-06-01 | 2017-06-05 | 9,062 | — | $0 | 0 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2017-06-01 | 2017-06-05 | 23,789 | — | $0 | 0 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2017-06-01 | 2017-06-05 | 10,195 | — | $0 | 0 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2017-06-01 | 2017-06-05 | 9,062 | $51.75 | $469.0K | 214,596 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2017-06-01 | 2017-06-05 | 10,195 | $38.80 | $395.6K | 224,791 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2017-06-01 | 2017-06-05 | 37,383 | $45.11 | $1.69M | 163,621 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2017-06-01 | 2017-06-05 | 18,124 | $48.74 | $883.4K | 181,745 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2017-06-01 | 2017-06-05 | 23,789 | $37.86 | $900.7K | 205,534 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-06-01 | 2017-06-05 | 98,553 | $124.00 | $12.22M | 126,238 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | A Award deriv | 2017-05-31 | 2017-06-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2017-05-25 | 2017-05-26 | 20,000 | — | $0 | 20,000 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2017-05-25 | 2017-05-26 | 4,000 | — | $0 | 4,000 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award | 2017-05-25 | 2017-05-26 | 22,988 | $1.74 | $40.0K | 22,988 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-05-15 | 2017-05-17 | 294 | $114.92 | $33.8K | 126,238 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-02-28 | 2017-03-02 | 3,842 | $90.00 | $345.8K | 126,238 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-02-13 | 2017-02-15 | 3,842 | $87.66 | $336.8K | 130,080 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2017-02-03 | 2017-02-07 | 31,065 | — | $0 | 31,065 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2017-02-03 | 2017-02-07 | 15,170 | — | $0 | 133,922 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2017-02-03 | 2017-02-07 | 5,753 | $0.01 | $58 | 118,752 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2017-01-06 | 2017-01-09 | 40,000 | — | $0 | 40,000 | SEC↗ |
| OPHT Ophthotech Corp. | A Award deriv | 2016-08-02 | 2016-08-04 | 20,000 | — | $0 | 20,000 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2016-06-17 | 2016-06-21 | 4,000 | — | $0 | 4,000 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2016-06-17 | 2016-06-21 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | A Award deriv | 2016-06-08 | 2016-06-10 | 15,000 | — | $0 | 15,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-05-16 | 2016-05-18 | 202 | $82.06 | $16.6K | 112,999 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-02-03 | 2016-02-04 | 4,232 | $90.97 | $385.0K | 115,851 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-02-03 | 2016-02-04 | 1,200 | $91.68 | $110.0K | 114,651 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-02-03 | 2016-02-04 | 1,652 | $92.73 | $153.2K | 112,999 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-02-03 | 2016-02-04 | 5,000 | $89.90 | $449.5K | 120,083 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2016-02-02 | 2016-02-04 | 34,482 | — | $0 | 34,482 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2016-02-02 | 2016-02-04 | 17,299 | $0.01 | $173 | 125,083 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | M Exercise deriv | 2016-01-04 | 2016-01-06 | 10,000 | — | $0 | 0 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | M Exercise deriv | 2016-01-04 | 2016-01-06 | 542 | — | $0 | 0 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | M Exercise deriv | 2016-01-04 | 2016-01-06 | 2,689 | — | $0 | 0 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | S Sale | 2016-01-04 | 2016-01-06 | 13,131 | $41.85 | $549.5K | 100 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | M Exercise | 2016-01-04 | 2016-01-06 | 542 | $22.13 | $12.0K | 542 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | M Exercise | 2016-01-04 | 2016-01-06 | 2,689 | $17.85 | $48.0K | 3,231 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | M Exercise | 2016-01-04 | 2016-01-06 | 10,000 | $18.21 | $182.1K | 13,231 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | S Sale | 2016-01-04 | 2016-01-06 | 100 | $42.26 | $4.2K | 0 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2015-10-30 | 2015-11-03 | 2,800 | $124.95 | $349.9K | 115,334 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2015-10-30 | 2015-11-03 | 2,685 | $126.62 | $340.0K | 107,784 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2015-10-30 | 2015-11-03 | 4,865 | $125.98 | $612.9K | 110,469 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2015-07-21 | 2015-07-23 | 34,000 | — | $0 | 34,000 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2015-06-15 | 2015-06-16 | 4,000 | — | $0 | 4,000 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2015-06-15 | 2015-06-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | A Award deriv | 2015-06-09 | 2015-06-11 | 15,000 | — | $0 | 15,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2015-05-15 | 2015-05-18 | 178 | $125.84 | $22.4K | 118,234 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2015-05-15 | 2015-05-18 | 100 | $126.99 | $12.7K | 118,134 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2015-05-15 | 2015-05-18 | 100 | $123.85 | $12.4K | 118,412 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2015-03-23 | 2015-03-24 | 1,000 | $126.65 | $126.7K | 118,634 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2015-03-23 | 2015-03-24 | 2,815 | $125.69 | $353.8K | 119,634 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2015-03-23 | 2015-03-24 | 1,327 | $124.87 | $165.7K | 122,449 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2015-03-23 | 2015-03-24 | 500 | $127.83 | $63.9K | 118,134 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2015-03-23 | 2015-03-24 | 200 | $122.44 | $24.5K | 123,976 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2015-03-23 | 2015-03-24 | 200 | $123.52 | $24.7K | 123,776 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2015-02-18 | 2015-02-20 | 5,250 | $112.66 | $591.5K | 129,276 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2015-02-18 | 2015-02-20 | 5,100 | $113.13 | $577.0K | 124,176 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2015-02-03 | 2015-02-05 | 68,000 | — | $0 | 68,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2015-02-03 | 2015-02-05 | 20,700 | $0.01 | $207 | 134,526 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2014-12-12 | 2014-12-16 | 2,880 | $120.44 | $346.9K | 113,826 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2014-12-12 | 2014-12-16 | 3,162 | $119.82 | $378.9K | 116,706 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2014-10-30 | 2014-11-03 | 75,000 | $0.01 | $750 | 119,868 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2014-09-30 | 2014-10-01 | 16,992 | — | $0 | 37,383 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2014-09-30 | 2014-10-01 | 18,126 | — | $0 | 18,124 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2014-09-30 | 2014-10-01 | 16,993 | — | $0 | 23,789 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2014-09-30 | 2014-10-01 | 11,330 | — | $0 | 9,062 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2014-09-30 | 2014-10-01 | 16,993 | — | $0 | 10,195 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2014-09-30 | 2014-10-01 | 11,329 | — | $0 | 0 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2014-09-30 | 2014-10-01 | 13,594 | — | $0 | 0 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2014-09-30 | 2014-10-01 | 2,267 | — | $0 | 0 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2014-09-30 | 2014-10-01 | 14,007 | $111.31 | $1.56M | 138,887 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2014-09-30 | 2014-10-01 | 16,992 | $45.11 | $766.5K | 152,894 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2014-09-30 | 2014-10-01 | 43,112 | $112.21 | $4.84M | 95,775 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2014-09-30 | 2014-10-01 | 28,751 | $113.10 | $3.25M | 67,024 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2014-09-30 | 2014-10-01 | 22,156 | $113.90 | $2.52M | 44,868 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2014-09-30 | 2014-10-01 | 18,126 | $48.74 | $883.5K | 135,902 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2014-09-30 | 2014-10-01 | 16,993 | $37.86 | $643.4K | 117,776 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2014-09-30 | 2014-10-01 | 11,330 | $51.75 | $586.3K | 100,783 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2014-09-30 | 2014-10-01 | 16,993 | $38.80 | $659.3K | 89,453 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2014-09-30 | 2014-10-01 | 11,329 | $33.82 | $383.1K | 72,460 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2014-09-30 | 2014-10-01 | 13,594 | $39.05 | $530.8K | 61,131 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2014-09-30 | 2014-10-01 | 2,267 | $33.28 | $75.4K | 47,537 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2014-07-15 | 2014-07-17 | 34,000 | — | $0 | 34,000 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2014-06-17 | 2014-06-19 | 15,000 | — | $0 | 15,000 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2014-06-17 | 2014-06-19 | 4,000 | — | $0 | 4,000 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | A Award deriv | 2014-06-05 | 2014-06-09 | 10,000 | — | $0 | 10,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2014-02-05 | 2014-02-07 | 68,000 | — | $0 | 68,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2014-02-05 | 2014-02-07 | 20,700 | $0.01 | $207 | 44,868 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2013-07-30 | 2013-08-01 | 34,000 | — | $0 | 34,000 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2013-06-11 | 2013-06-13 | 4,000 | — | $0 | 4,000 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2013-06-11 | 2013-06-13 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | A Award deriv | 2013-05-30 | 2013-06-03 | 10,000 | — | $0 | 10,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2013-05-15 | 2013-05-17 | 100 | $80.50 | $8.1K | 24,168 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2013-05-15 | 2013-05-17 | 509 | $79.51 | $40.5K | 24,268 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2013-04-19 | 2013-04-23 | 28,570 | — | $0 | 0 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2013-04-19 | 2013-04-23 | 54,375 | — | $0 | 0 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2013-04-19 | 2013-04-23 | 36,250 | — | $0 | 0 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2013-04-19 | 2013-04-23 | 73,500 | — | $0 | 0 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2013-04-19 | 2013-04-23 | 40,781 | — | $0 | 13,594 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2013-04-19 | 2013-04-23 | 300,000 | — | $0 | 0 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2013-04-19 | 2013-04-23 | 33,983 | — | $0 | 2,267 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2013-04-19 | 2013-04-23 | 24,921 | — | $0 | 11,329 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2013-04-19 | 2013-04-23 | 27,187 | — | $0 | 27,188 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2013-04-19 | 2013-04-23 | 15,858 | — | $0 | 20,392 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2013-04-19 | 2013-04-23 | 13,593 | — | $0 | 40,782 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2013-04-19 | 2013-04-23 | 54,375 | — | $0 | 0 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2013-04-19 | 2013-04-23 | 36,250 | — | $0 | 0 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2013-04-19 | 2013-04-23 | 27,187 | $38.80 | $1.05M | 73,255 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2013-04-19 | 2013-04-23 | 691,318 | $81.50 | $56.34M | 78,535 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2013-04-19 | 2013-04-23 | 13,593 | $37.86 | $514.6K | 769,853 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2013-04-19 | 2013-04-23 | 300,000 | $33.00 | $9.90M | 756,260 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2013-04-19 | 2013-04-23 | 73,500 | $35.64 | $2.62M | 456,260 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2013-04-19 | 2013-04-23 | 36,250 | $32.16 | $1.17M | 382,760 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2013-04-19 | 2013-04-23 | 28,570 | $28.84 | $824.0K | 346,510 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2013-04-19 | 2013-04-23 | 54,375 | $36.30 | $1.97M | 317,940 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2013-04-19 | 2013-04-23 | 36,250 | $35.35 | $1.28M | 263,565 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2013-04-19 | 2013-04-23 | 33,983 | $33.28 | $1.13M | 227,315 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2013-04-19 | 2013-04-23 | 54,375 | $33.55 | $1.82M | 193,332 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2013-04-19 | 2013-04-23 | 40,781 | $39.05 | $1.59M | 138,957 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2013-04-19 | 2013-04-23 | 24,921 | $33.82 | $842.8K | 98,176 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2013-04-19 | 2013-04-23 | 54,367 | $85.00 | $4.62M | 24,168 | SEC↗ |